Botanix has an exclusive license to use a proprietary drug delivery system called Permetrex™, for direct skin delivery of pharmaceuticals. This platform technology is at the heart of Botanix’s product pipeline, providing a targeted and effective mode of delivery for a range of novel treatments – including synthetic cannabidiol or CBD.
Delivering pharmaceuticals to the skin to treat disease is challenging. The skin’s role is to protect the body from a range of chemical and environmental assaults, so bypassing this active system requires an innovative approach. Botanix has exclusively licensed a novel transdermal drug delivery solution known as Permetrex™, which is designed to deliver pharmaceuticals through the skin more effectively. Right to where treatment is needed most.
So what makes Permetrex™ unique?
Botanix is currently actively working with pharmaceutical partners who are using the Permetrex™ delivery system.
Permetrex™ drives pharmaceuticals deep into the skin where their action is required – otherwise the drug remains in the outer layers of the skin.